Sim&Cure develops the medical software Sim&Size® to optimize the choice of endovascular devices for the treatment of cerebral aneurysm.
Sim&Cure has raised $11.6M in total funding. The most recent round was Series A. The last funding was announced in November 2025.
Sim&Cure's investors include Swen Capital Partners, Elaia, Tudigo, IRDI SORIDEC Gestion, Holnest.
Sim&Cure is headquartered in Grabels, France.
Sim&Cure develops the medical software Sim&Size® to optimize the choice of endovascular devices for the treatment of cerebral aneurysm.
Sim&Cure is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sim&Cure — Funding & Investors." VCBacked, November 28, 2025, https://www.vcbacked.co/company/simcure. Accessed August 14, 2026.
VCBacked. (2025). Sim&Cure — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/simcure
{{cite web |title=Sim&Cure — Funding & Investors |url=https://www.vcbacked.co/company/simcure |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated